MAR 28, 2019 8:00 PM PDT

A Rare and Potent Sea Fighter: An End to Melanoma Cells?

WRITTEN BY: Nupur Srivastava

Melanoma is cancer that usually starts in a particular type of skin cell as melanocytes. It can be more severe than other forms of skin cancer because of a tendency to spread to other parts of the body (metastasize) and cause extreme illness and death. The rates of melanoma have been rising for the last 50 years in the United States. This year, melanoma will affect 96,480 people and kill 7,230 in the United States, according to the latest estimates. As melanoma spreads fast and migrates to other locations in the body, its prognosis is hard, and scientists are looking for effective ways to treat melanoma. New therapeutic inhibitors “BRAF” mutations are effective drugs for melanoma treatment. However, almost half of the patients did not respond to the remedy and the remaining patients developed resistance to the drugs in a few months, rendering the treatment ineffective.

While trying to explore alternative ways for the prevention of the melanoma, the researchers discovered a natural product, seriniquinone, isolated from a rare marine bacterium of the genus, Serinicoccus, to be dominant and selective against melanoma cells. The investigators from the University of California in San Diego, Universidade Federal de São Paulo and Universidade de São Paulo in Brazil published their work in ACS Medicinal Chemistry Letters. William Fenical, James J. La Clair, and Leticia Costa-Lotufo were the leaders of the research team. In one of the publications in the year 2014, their studies determine that seriniquinone aids in destroying the melanoma cells in the laboratory by targeting and inducing cell death of dermcidin, a protein highly expressed in melanoma cells.

With the discovery of these molecules, the scientists tried modifying the structure of the particles to make it water-soluble and more accessible to purify. Without changing the anti-cancer property of seriniquinone, researchers were successful in making it more useful for a person with the disease, rather than being limited to the test tubes. The authors wrote, “The translation of seriniquinone into a chemotherapeutic agent is complex. It requires significant medicinal chemistry efforts to generate a large number of derivatives to improve its ‘drug-like’ properties.” They say, “Overall, these studies suggest that it is feasible to design melanoma-specific seriniquinone derivatives with drug-like properties.”

The research team is closer to designing and marketing the right drug as they are developing ways to optimize the action of these seriniquinone derivatives for more targeted therapy of melanoma.

Sources: ACS Newsletter, EurekAlert!, PNAS, Oncotarget, ACS Medicinal Chemistry Letter

About the Author
You May Also Like
NOV 11, 2020
Health & Medicine
A smart path for novel biologics
NOV 11, 2020
A smart path for novel biologics
Introduction  Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the o ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
NOV 05, 2020
Immunology
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
NOV 05, 2020
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
Our knowledge of COVID-19 or SARS-CoV-2 is increasing every day, with new research papers published continuously. Resear ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
NOV 24, 2020
Cardiology
Patients on Statins Get the 'Nocebo Effect'
NOV 24, 2020
Patients on Statins Get the 'Nocebo Effect'
Millions of people around the world take statins to treat high cholesterol, which are estimated to reduce the risk of he ...
NOV 23, 2020
Health & Medicine
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
NOV 23, 2020
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
Concerns that the legalization of recreational marijuana might cause an upswing in young people misusing the drug have b ...
Loading Comments...